Association ofTERTPromoter Mutation 1,295,228 C>T WithBRAFV600E Mutation, Older Patient Age, and Distant Metastasis in Anaplastic Thyroid Cancer
Author(s) -
Xiaoguang Shi,
Rengyun Liu,
Shen Qu,
Guangwu Zhu,
Justin A. Bishop,
Xiaoli Liu,
Hui Sun,
Zhongyan Shan,
Enhua Wang,
Yahong Luo,
Xianghong Yang,
Jiajun Zhao,
Jianling Du,
Adel K. ElNaggar,
Weiping Teng,
Mingzhao Xing
Publication year - 2015
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2014-3606
Subject(s) - anaplastic thyroid cancer , odds ratio , thyroid cancer , medicine , mutation , metastasis , cancer , confidence interval , oncology , cancer research , gastroenterology , biology , genetics , gene
The aggressive role of TERT promoter mutations has been well established in differentiated thyroid cancer but has not been established in anaplastic thyroid cancer (ATC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom